Insights into corrosion behaviour of uncoated Mg alloys for biomedical applications in different aqueous media
Source abstract
Abstract
MgCa and MgGd series of alloys are often reported as promising candidates for biomedical applications. In the present study, cytotoxicity and corrosion behavior of Mg1Ca and Mg10Gd alloys in different electrolytes (NaCl, PBS, MEM) have been investigated in order to make a direct comparison and understand the mechanisms behind their performance. Potentiodynamic polarization and electrochemical impedance spectroscopy (EIS) were employed to analyze corrosion processes depending on media composition, whereas X-Ray diffraction (XRD) and scanning electron microscopy (SEM) were used to evaluate crystalline structure, phase composition and surface morphology of the corroded substrates after immersion in the different electrolytes. Moreover, cytotoxicity of the Mg alloys was assessed using the WST-1 reduction and lactate dehydrogenase (LDH) release assays in L929 mouse fibroblasts. The electrochemical results showed that Mg1Ca has a lower degradation rate when compared to Mg10Gd, due to the lower microgalvanic effects and the presence of Ca as an alloying element. Furthermore, the corrosion activity is reduced in MEM, for both alloys, when compared to NaCl and PBS. The cytotoxicity assays revealed that Mg10Gd was cytotoxic in all the conditions tested, while the toxicity of Mg1Ca was low. Overall, these findings show that Mg1Ca alloy presents a higher corrosion resistance and biocompatibility and is a promising material to be used in biomedical implants.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Corrosion Behavior and Inhibition · Aluminum Alloys Composites Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Magnesium and its alloys as orthopedic biomaterials: a review10.1016/j.biomaterials.2005.10.003 ↗
2. Surface modifications of magnesium alloys for biomedical applications10.1007/s10439-011-0300-y ↗
3. Bio-corrosion characterization of Mg-Zn-X (X = Ca, Mn, Si) alloys for biomedical applications10.1007/s10856-009-3956-1 ↗
4. Biomedical coatings on magnesium alloys - a review10.1016/j.actbio.2012.04.012 ↗
5. Fundamentals and advances in magnesium alloy corrosion10.1016/j.pmatsci.2017.04.011 ↗
6. Biodegradable metals10.1016/j.mser.2014.01.001 ↗
7. Mg bone implant: features, developments and perspectives10.1016/j.matdes.2019.108259 ↗
8. Biomaterials in orthopaedics10.1098/rsif.2008.0151 ↗
9. Corrosion mechanisms of magnesium alloys10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N ↗
10. Understandings magnesium corrosion10.1002/adem.200310405 ↗
11. Corrosion types of magnesium alloys
12. Degradable biomaterials based on magnesium corrosion10.1016/j.cossms.2009.04.001 ↗
13. Mg alloys development and surface modification for biomedical application
14. Recent advances on the development of magnesium alloys for biodegradable implants10.1016/j.actbio.2014.07.005 ↗
15. Atomic layer deposited ZrO2 nanofilm on Mg-Sr alloy for enhanced corrosion resistance and biocompatibility10.1016/j.actbio.2017.06.015 ↗
16. Controlling initial biodegradation of magnesium by a biocompatible strontium phosphate conversion coating10.1016/j.actbio.2013.11.016 ↗
17. Structure and properties of compound coatings on Mg alloys by micro-arc oxidation/hydrothermal treatment10.1016/j.jallcom.2015.02.008 ↗
18. 14 - polymer-based degradable coatings for metallic biomaterials
19. Influence of artificial biological fluid composition on the biocorrosion of potential orthopedic Mg-Ca, AZ31, AZ91 alloys10.1088/1748-6041/4/6/065011 ↗
20. Influence of Tris in simulated body fluid on degradation behavior of pure Magnesium10.1016/j.matchemphys.2010.07.010 ↗
21. Influence of test solutions on in vitro studies of biomedical magnesium alloys10.1149/1.3421651 ↗
22. Magnesium degradation influenced by buffering salts in concentrations typical of in vitro and in vivo models10.1016/j.msec.2015.09.067 ↗
23. Effect of inorganic salts, amino acids and proteins on the degradation of pure magnesium in vitro10.1016/j.msec.2008.12.015 ↗
24. The role of individual components of simulated body fluid on the corrosion behavior of commercially pure Mg10.1016/j.corsci.2018.11.011 ↗
25. In vivo corrosion of four magnesium alloys and the associated bone response10.1016/j.biomaterials.2004.09.049 ↗
26. In vitro and in vivo corrosion measurements of magnesium alloys10.1016/j.biomaterials.2005.07.037 ↗
27. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?10.1136/heart.89.6.651 ↗
28. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia10.1583/04-1349R.1 ↗
29. Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment)10.1016/S1043-6618(02)00336-5 ↗
30. Differences in behavior among the chlorides of seven rare earth elements administered intravenously to rats10.1006/faat.1997.2322 ↗
31. Novel magnesium alloys developed for biomedical application: a review10.1016/j.jmst.2013.02.005 ↗
32. Effect of heat treatment on the corrosion behavior of Mg-10Gd alloy in 0.5% NaCl solution
33. ISO10993-4, Biological evaluation of medical devices - Part 4: selection of tests for interactions with blood.
34. The anodic dissolution of magnesium in chloride and sulphate solutions10.1016/S0010-938X(97)00090-5 ↗
35. Assessing the corrosion of biodegradable magnesium implants: a critical review of current methodologies and their limitations10.1016/j.actbio.2011.11.014 ↗
36. Unexpected formation of hydrides in heavy rare earth containing magnesium alloys10.1016/j.jma.2016.08.002 ↗
37. Accurate electrochemical measurement of magnesium corrosion rates; a combined impedance, mass-loss and hydrogen collection study10.1016/j.electacta.2013.12.124 ↗
38. The anodic surface film and hydrogen evolution on Mg10.1016/j.corsci.2015.05.047 ↗
39. Approaching "stainless magnesium" by Ca micro-alloying10.1039/D0MH01380C ↗
40. Magnesium-based biodegradable alloys: degradation, application, and alloying elements10.1556/1646.9.2017.1.04 ↗
41. Fabrication and properties of magnesium based alloys Mg-Ca
42. Magnesium alloys as implant materials--principles of property design for Mg-RE alloys10.1016/j.actbio.2009.09.010 ↗
43. Corrosion performance and mechanical properties of sputter-deposited MgY and MgGd alloys10.1016/j.corsci.2013.08.027 ↗
44. In vitro and in vivo biocompatibility of Mg-Zn-Ca alloy operative clip10.1016/j.bioactmat.2019.07.002 ↗
45. In-vitro cytotoxicity and in-vivo biocompatibility of as-extruded Mg-4.0Zn-0.2Ca alloy10.1016/j.msec.2012.01.004 ↗
46. Mechanical properties, degradation performance and cytotoxicity of Mg-Zn-Ca biomedical alloys with different compositions10.1016/j.msec.2011.07.015 ↗
47. Cytotoxicity studies of AZ31D alloy and the effects of carbon dioxide on its biodegradation behavior in vitro10.1016/j.msec.2013.06.041 ↗
48. Reprint of: improved cytotoxicity testing of magnesium materials
49. Influence of the extraction parameters on the cytotoxicity test results of Mg materials10.1016/j.pnsc.2014.09.005 ↗
50. Effect of zinc and rare-earth element addition on mechanical, corrosion, and biological properties of magnesium10.1557/jmr.2018.311 ↗
51. Gadolinium accumulation in organs of Sprague-Dawley (R) rats after implantation of a biodegradable magnesium-gadolinium alloy10.1016/j.actbio.2016.11.024 ↗
52. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms10.1007/s10534-016-9931-7 ↗